Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Levesque

Showing results (91-100 of 123) with videos related to

Pageof 13
Sort By:
Inflammatory Bowel Diseases|January 14, 2014
Histologic evaluation of ulcerative colitis: a systematic review of disease activity indicesMahmoud H Mosli, Brian G Feagan, William J Sandborn, et al.
Inflammatory Bowel Diseases|December 10, 2024
Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION StudyHiroshi Nakase, Silvio Danese, Walter Reinisch, et al.
Alimentary Pharmacology & Therapeutics|April 3, 2014
A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's diseaseB G Levesque, G R Greenberg, G Zou, et al.
Neurobiology of Disease|January 1, 1997
Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissueM B Podlisny, M Citron, P Amarante, et al.
Genomics|March 15, 1997
Analysis of the 5' sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer diseaseE I Rogaev, R Sherrington, C Wu, et al.
Gut|October 23, 2014
The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's diseaseNiels Vande Casteele, Reena Khanna, Barrett G Levesque, et al.
Alimentary Pharmacology & Therapeutics|July 22, 2014
Validated gene expression biomarker analysis for biopsy-based clinical trials in ulcerative colitisB S Boland, D L Boyle, W J Sandborn, et al.
Inflammatory Bowel Diseases|December 30, 2014
Validation of gene expression biomarker analysis for biopsy-based clinical trials in Crohn's diseaseBrigid S Boland, David L Boyle, William J Sandborn, et al.
Neuroscience Letters|August 26, 1998
Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOEY Q Song, E Rogaeva, S Premkumar, et al.
Alimentary Pharmacology & Therapeutics|January 11, 2022
Randomised clinical trial: a phase 1b study of GB004, an oral HIF-1α stabiliser, for treatment of ulcerative colitisSilvio Danese, Barrett G Levesque, Brian G Feagan, et al.
Pageof 13

Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Inflammatory Bowel Diseases|January 14, 2014
Histologic evaluation of ulcerative colitis: a systematic review of disease activity indicesMahmoud H Mosli, Brian G Feagan, William J Sandborn, et al.
Inflammatory Bowel Diseases|December 10, 2024
Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION StudyHiroshi Nakase, Silvio Danese, Walter Reinisch, et al.
Alimentary Pharmacology & Therapeutics|April 3, 2014
A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's diseaseB G Levesque, G R Greenberg, G Zou, et al.
Neurobiology of Disease|January 1, 1997
Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissueM B Podlisny, M Citron, P Amarante, et al.
Genomics|March 15, 1997
Analysis of the 5' sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer diseaseE I Rogaev, R Sherrington, C Wu, et al.
Gut|October 23, 2014
The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's diseaseNiels Vande Casteele, Reena Khanna, Barrett G Levesque, et al.
Alimentary Pharmacology & Therapeutics|July 22, 2014
Validated gene expression biomarker analysis for biopsy-based clinical trials in ulcerative colitisB S Boland, D L Boyle, W J Sandborn, et al.
Inflammatory Bowel Diseases|December 30, 2014
Validation of gene expression biomarker analysis for biopsy-based clinical trials in Crohn's diseaseBrigid S Boland, David L Boyle, William J Sandborn, et al.
Neuroscience Letters|August 26, 1998
Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOEY Q Song, E Rogaeva, S Premkumar, et al.
Alimentary Pharmacology & Therapeutics|January 11, 2022
Randomised clinical trial: a phase 1b study of GB004, an oral HIF-1α stabiliser, for treatment of ulcerative colitisSilvio Danese, Barrett G Levesque, Brian G Feagan, et al.
Pageof 13